My NCBI | Sign In
Search: cytomegalovirus infections[majr] AND english[la] AND humans[mh] AND (jsubsetk[text] OR review[pt] OR guideline[pt] OR clinical trial[pt] OR patient education handout[pt] OR systematic[sb]) NOT (letter[pt] OR editorial[pt] OR case reports[pt]) AND "last 1 Year"[edat]
RSS Settings
  • Search: cytomegalovirus infections[majr] AND english[la] AND humans[mh...

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 43

    1.

    Multicenter quality control study for human cytomegalovirus DNAemia quantification.

    Lilleri D, Lazzarotto T, Ghisetti V, Ravanini P, Capobianchi MR, Baldanti F, Gerna G; SIV-AMCLI Transplant Surveillance Group.

    New Microbiol. 2009 Jul;32(3):245-53.PMID: 19845106 [PubMed - indexed for MEDLINE]Related articles

    2.

    Impact of genetic polymorphisms in cytomegalovirus glycoprotein B on outcomes in solid-organ transplant recipients with cytomegalovirus disease.

    Manuel O, Asberg A, Pang X, Rollag H, Emery VC, Preiksaitis JK, Kumar D, Pescovitz MD, Bignamini AA, Hartmann A, Jardine AG, Humar A.

    Clin Infect Dis. 2009 Oct 15;49(8):1160-6.PMID: 19751151 [PubMed - indexed for MEDLINE]Related articles

    3.

    Antivirals for cytomegalovirus infection in neonates and infants: focus on pharmacokinetics, formulations, dosing, and adverse events.

    Marshall BC, Koch WC.

    Paediatr Drugs. 2009;11(5):309-21. doi: 10.2165/11316080-000000000-00000. Review.PMID: 19725597 [PubMed - indexed for MEDLINE]Related articles

    4.

    Cytomegalovirus resistance in solid organ transplant recipients treated with intravenous ganciclovir or oral valganciclovir.

    Boivin G, Goyette N, Rollag H, Jardine AG, Pescovitz MD, Asberg A, Ives J, Hartmann A, Humar A.

    Antivir Ther. 2009;14(5):697-704.PMID: 19704173 [PubMed - indexed for MEDLINE]Related articles

    5.

    Prevention of cytomegalovirus disease using pre-emptive treatment after solid organ transplant in patients at high risk for cytomegalovirus infection.

    Benmarzouk-Hidalgo OJ, Cordero E, Martín-Peña A, García-Prado E, Gentil MA, Gomez-Bravo MA, Barrera-Pulido L, Cisneros JM, Perez-Romero P.

    Antivir Ther. 2009;14(5):641-7.PMID: 19704166 [PubMed - indexed for MEDLINE]Related articles

    6.

    Molecular targets for antiviral therapy of cytomegalovirus infections.

    Marschall M, Stamminger T.

    Future Microbiol. 2009 Aug;4:731-42. Review.PMID: 19659428 [PubMed - indexed for MEDLINE]Related articles

    7.

    Low rate of CMV end-organ disease in HIV-infected patients despite low CD4+ cell counts and CMV viremia: results of ACTG protocol A5030.

    Wohl DA, Kendall MA, Andersen J, Crumpacker C, Spector SA, Feinberg J, Alston-Smith B, Owens S, Chafey S, Marco M, Maxwell S, Lurain N, Jabs D, Benson C, Keiser P, Jacobson MA; A5030 Study Team.

    HIV Clin Trials. 2009 May-Jun;10(3):143-52.PMID: 19632953 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Cytomegalovirus and varicella-zoster virus vaccines in hematopoietic stem cell transplantation.

    Herr W, Plachter B.

    Expert Rev Vaccines. 2009 Aug;8(8):999-1021. Review.PMID: 19627184 [PubMed - indexed for MEDLINE]Related articles

    9.

    Cytomegalovirus prevention in high-risk lung transplant recipients: comparison of 3- vs 12-month valganciclovir therapy.

    Jaksch P, Zweytick B, Kerschner H, Hoda AM, Keplinger M, Lang G, Aigner C, Klepetko W.

    J Heart Lung Transplant. 2009 Jul;28(7):670-5. Epub 2009 May 13.PMID: 19560694 [PubMed - indexed for MEDLINE]Related articles

    10.

    Prevalence and mortality associated with cytomegalovirus infection in nonimmunosuppressed patients in the intensive care unit.

    Kalil AC, Florescu DF.

    Crit Care Med. 2009 Aug;37(8):2350-8. Review.PMID: 19531944 [PubMed - indexed for MEDLINE]Related articles

    11.

    The prevention and treatment of cytomegalovirus infection in haematopoietic stem cell transplantation.

    Tuthill M, Chen F, Paston S, De La Peña H, Rusakiewicz S, Madrigal A.

    Cancer Immunol Immunother. 2009 Sep;58(9):1481-8. Epub 2009 May 23. Review.PMID: 19466407 [PubMed - indexed for MEDLINE]Related articles

    12.

    The risk, prevention, and outcome of cytomegalovirus after pediatric lung transplantation.

    Danziger-Isakov LA, Worley S, Michaels MG, Arrigain S, Aurora P, Ballmann M, Boyer D, Conrad C, Eichler I, Elidemir O, Goldfarb S, Mallory GB, Mogayzel PJ, Parakininkas D, Solomon M, Visner G, Sweet S, Faro A.

    Transplantation. 2009 May 27;87(10):1541-8.PMID: 19461492 [PubMed - indexed for MEDLINE]Related articles

    13.

    Adoptive T cell immunotherapy for cytomegalovirus.

    Peggs KS.

    Expert Opin Biol Ther. 2009 Jun;9(6):725-36. Review.PMID: 19456207 [PubMed - indexed for MEDLINE]Related articles

    14.

    Incidence, risk factors, and outcome of cytomegalovirus infection and disease in patients receiving prophylaxis with oral valganciclovir or intravenous ganciclovir after umbilical cord blood transplantation.

    Montesinos P, Sanz J, Cantero S, Lorenzo I, Martín G, Saavedra S, Palau J, Romero M, Montava A, Senent L, Martínez J, Jarque I, Salavert M, Córdoba J, Gómez L, Weiss S, Moscardó F, de la Rubia J, Larrea L, Sanz MA, Sanz GF.

    Biol Blood Marrow Transplant. 2009 Jun;15(6):730-40. Epub 2009 Apr 11.PMID: 19450758 [PubMed - indexed for MEDLINE]Related articles

    15.

    Cytomegalovirus infection in critically ill patients: a systematic review.

    Osawa R, Singh N.

    Crit Care. 2009;13(3):R68. Epub 2009 May 14. Review.PMID: 19442306 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Valganciclovir for cytomegalovirus prevention in solid organ transplant patients: an evidence-based reassessment of safety and efficacy.

    Kalil AC, Freifeld AG, Lyden ER, Stoner JA.

    PLoS One. 2009;4(5):e5512. Epub 2009 May 13.PMID: 19436751 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Function of human cytomegalovirus UL97 kinase in viral infection and its inhibition by maribavir.

    Prichard MN.

    Rev Med Virol. 2009 Jul;19(4):215-29. Review.PMID: 19434630 [PubMed - indexed for MEDLINE]Related articles

    18.

    Long-term outcomes of CMV disease treatment with valganciclovir versus IV ganciclovir in solid organ transplant recipients.

    Asberg A, Humar A, Jardine AG, Rollag H, Pescovitz MD, Mouas H, Bignamini A, Töz H, Dittmer I, Montejo M, Hartmann A; VICTOR Study Group.

    Am J Transplant. 2009 May;9(5):1205-13.PMID: 19422345 [PubMed - indexed for MEDLINE]Related articles

    19.

    Antiviral therapy for herpesvirus central nervous system infections: neonatal herpes simplex virus infection, herpes simplex encephalitis, and congenital cytomegalovirus infection.

    James SH, Kimberlin DW, Whitley RJ.

    Antiviral Res. 2009 Sep;83(3):207-13. Epub 2009 May 4. Review.PMID: 19414035 [PubMed - indexed for MEDLINE]Related articles

    20.

    Dendritic cells in cytomegalovirus infection: viral evasion and host countermeasures.

    Rölle A, Olweus J.

    APMIS. 2009 May;117(5-6):413-26. Review.PMID: 19400865 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Filter your results:

    3 free full-text articles in PubMed Central

    Find related data

    Search details

    » See more...

    Recent activity